| ALT neuroblastoma chemoresistance due to telomere dysfunction–induced ATM activation is reversible with ATM inhibitor AZD0156 B Koneru, A Farooqi, TH Nguyen, WH Chen, A Hindle, C Eslinger, ... Science translational medicine 13 (607), eabd5750, 2021 | 39 | 2021 |
| Fenretinide via NOXA induction, enhanced activity of the BCL-2 inhibitor venetoclax in high BCL-2–expressing neuroblastoma preclinical models TH Nguyen, B Koneru, SJ Wei, WH Chen, MR Makena, E Urias, MH Kang, ... Molecular cancer therapeutics 18 (12), 2270-2282, 2019 | 18 | 2019 |
| Vorinostat and fenretinide synergize in preclinical models of T-cell lymphoid malignancies MR Makena, TH Nguyen, B Koneru, A Hindle, WH Chen, DU Verlekar, ... Anti-Cancer Drugs 32 (1), 34-43, 2021 | 8 | 2021 |
| The O6-methyguanine-DNA methyltransferase inhibitor O6-benzylguanine enhanced activity of temozolomide+ irinotecan against models of high-risk neuroblastoma A Hindle, B Koneru, MR Makena, L Lopez-Barcons, WH Chen, ... Anti-cancer drugs 32 (3), 233-247, 2021 | 5 | 2021 |
| Vorinostat and fenretinide synergize in preclinical models of T-cell lymphoid malignancies via reactive oxygen species MR Makena, TH Nguyen, B Koneru, A Hindle, WH Chen, DU Verlekar, ... Cancer Research 78 (13_Supplement), 4812-4812, 2018 | 3 | 2018 |
| Impact of Bmal1 rescue and time-restricted feeding on liver and muscle proteomes during the active phase in mice JG Smith, J Molendijk, R Blazev, WH Chen, Q Zhang, C Litwin, VM Zinna, ... Molecular & Cellular Proteomics 22 (11), 2023 | 2 | 2023 |
| ALT Neuroblastoma Chemoresistance due to ATM Activation by Telomere Dysfunction is Reversible with the ATM Inhibitor AZD0156 B Koneru, A Farooqi, TH Nguyen, WH Chen, A Hindle, C Eslinger, ... bioRxiv, 2021.04. 06.438692, 2021 | 1 | 2021 |
| Ketogenic diet induces p53-dependent cellular senescence in multiple organs SJ Wei, JR Schell, ES Chocron, M Varmazyad, G Xu, WH Chen, ... Science Advances 10 (20), eado1463, 2024 | | 2024 |
| MGMT Inhibitor O6-Benzylguanine Enhanced the Activity of Temozolomide plus Irinotecan against in Vitro and in Vivo Models of Progressive Disease High-Risk Neuroblastoma A Hindle, M Makena, B Koneru, T Nguyen, WH Chen, CP Reynolds PEDIATRIC BLOOD & CANCER 64, S122-S122, 2017 | | 2017 |
| atm inhiBition sensitizes alt neuroBlastomas to chemotherapy B Koneru, A Farooqi, TH Nguyen, WH Chen, A Hindle, C Eslinger | | |
